PART I Item 1. B usiness Unless the context requires otherwise, the words MannKind, we, Company, us and our refer to MannKind Corporation and its subsidiaries. We are a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart fail...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073516 | EDGAR | 98K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027735 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021423 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001564590-23-002309 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006702 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008440 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001564590-20-006198 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001564590-19-004263 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003510 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001193125-17-085519 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-335054 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001193125-25-265813 | EDGAR | 68K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103535 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066429 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123296 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092288 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055661 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060253 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039074 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019668 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001564590-22-036933 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028753 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001193125-26-335016 | EDGAR | — |
| 2026-07-24 | 0001193125-26-316041 | EDGAR | — |
| 2026-02-26 | 0001193125-26-073509 | EDGAR | 5K words |
| 2025-11-10 | 0001193125-25-273321 | EDGAR | — |
| 2025-11-05 | 0001193125-25-265810 | EDGAR | — |
| 2025-10-09 | 0001193125-25-236064 | EDGAR | — |
| 2025-08-27 | 0000950170-25-111586 | EDGAR | — |
| 2025-08-25 | 0001193125-25-186994 | EDGAR | — |
| 2025-08-06 | 0000950170-25-103532 | EDGAR | — |
| 2025-05-19 | 0000950170-25-074523 | EDGAR | — |
285 total filings indexed. 253 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000899460 |
| Ticker | MNKD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.mannkindcorp.com |
| Listed | 2004-07-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MNKD (~200 tokens, structured JSON with cryptographic provenance)